PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.96%
Revenue growth under 50% of 2127.T's 59.47%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.17%
Gross profit growth under 50% of 2127.T's 107.47%. Michael Burry would be concerned about a severe competitive disadvantage.
24.49%
EBIT growth below 50% of 2127.T's 163.89%. Michael Burry would suspect deeper competitive or cost structure issues.
28.69%
Operating income growth under 50% of 2127.T's 160.77%. Michael Burry would be concerned about deeper cost or sales issues.
-17.71%
Negative net income growth while 2127.T stands at 194.76%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.71%
Negative EPS growth while 2127.T is at 194.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.71%
Negative diluted EPS growth while 2127.T is at 190.94%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x 2127.T's 0.01%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 2127.T's 1.22%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.57%
10Y revenue/share CAGR under 50% of 2127.T's 536.12%. Michael Burry would suspect a lasting competitive disadvantage.
-15.64%
Negative 5Y CAGR while 2127.T stands at 448.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
32.43%
3Y revenue/share CAGR under 50% of 2127.T's 168.54%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.27%
Below 50% of 2127.T's 781.65%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-21.87%
Negative 5Y net income/share CAGR while 2127.T is 867.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
70.89%
Below 50% of 2127.T's 253.04%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
24.39%
Below 50% of 2127.T's 155.01%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
70.99%
3Y equity/share CAGR 1.25-1.5x 2127.T's 60.86%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.55%
AR growth is negative/stable vs. 2127.T's 340.38%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.14%
We show growth while 2127.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.08%
Similar asset growth to 2127.T's 1.93%. Walter Schloss finds parallel expansions or investment rates.
4.03%
Under 50% of 2127.T's 8.09%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-30.60%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
94.28%
SG&A growth well above 2127.T's 17.09%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.